Company name:

CareDx Inc

  • IPO SHARE PRICE:
    $10.00
  • IPO DATE:
    July 17, 2014
  • TICKER:
    CDNA
  • MAIN STOCK EXCHANGE:
    NASDAQ
  • CURRENT HQ LOCATION:
    1 Tower Place South San Francisco California 94080
  • FISCAL YEAR END:
    December 31
  • INCORPORATION JURISDICTION:
    DE
  • ORGANIZED AS THE FOLLOWING LEGAL TYPE:
    Corporation
  • Investor Relations Webpage:
    Coming soon!
  • TAX RATE:
    USA federal corporate nominal income tax rate is 21%

Short Description

CareDx Inc

We are working hard and as soon as possible to provide company description soon. Feel free to reach out to request it sooner: improve@real-clear-investing.com

Statement of Cash Flow

Quarterly Annual
(USD in thousand)
Selected Year:
31-Dec
2020
OPERATING ACTIVITIES
Cash received and spent on operating activites of business — buying materials, paying salaries, receiving payments from clients, etc
34.3% - Stock-based compensation
30.0% - Refund liability - CMS advance payment
10.3% - Depreciation and amortization
8.4% - Accrued compensation and employee benefits
6.4% - Accounts payable
4.3% - Accrued and other liabilities
3.7% - Amortization of right-of-use assets
2.2% - Change in fair value of warrant liability
0.5% - Acquisition-related contingent consideration fair value adjustments
SOURCEs
10.3% 3.7% 6.4% 30.0% 8.4% 4.3% 34.3%
100 %
0%
USES
49.0% 15.2% 4.7% 27.4%
27.4% - Net income (loss)
15.2% - Accounts receivable
4.7% - Inventory
2.2% - Operating lease liabilities
1.5% - Deferred income taxes
0.1% - Prepaid and other assets
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Net income (loss)
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 ($47) ($22) ($18,714) ($18,714) ($14,060)
Depreciation and amortization
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 4 6 7,006 7,006 7,816
Amortization of deferred revenue
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 - - - - -
Amortization of right-of-use assets
-
-
-
-
-
-
 - 1,621 2,538 2,538 2,568
Amortization of inventory fair market value adjustment Amortization of inventory fair market value adjustment
-
-
$45,679
$45,679
$45,679
$45,679
 0 - - - -
Amortization of debt discount and non-cash interest expense Amortization of debt discount and non-cash interest expense
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 2 - - - -
Stock-based compensation
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 7 22 23,401 23,401 23,908
Lease expense
-
-
-
-
-
-
 - 2 - - -
Income tax benefit in connection with business acquisitions Income tax benefit in connection with business acquisitions
$45,679
$45,679
$45,679
-
-
-
 - - - - -
Deferred income taxes
-
-
$45,679
$45,679
$45,679
$45,679
 (2) (1) (1,023) (1,023) (576)
Loss on goodwill impairment
-
-
$45,679
$45,679
$45,679
$45,679
 - - - - -
(Gain) loss on sale of property and equipment
-
$45,679
$45,679
$45,679
$45,679
$45,679
 - 0 - - -
Loss on conversion of debt to equity
-
-
-
$45,679
-
-
 - - - - -
Change in fair value of warrant liability
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 23 (0) 1,495 1,495 5,980
Acquisition-related contingent consideration fair value adjustments Acquisition-related contingent consideration fair value adjustments
-
$45,679
$45,679
$45,679
$45,679
$45,679
 1 0 309 309 32
Debt repayment expenses
-
-
-
-
$45,679
$45,679
 6 - - - -
Accounts receivable
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 (4) (13) (10,402) (10,402) (20,172)
Inventory
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 0 (1) (3,196) (3,196) 1,648
Prepaid and other assets
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 (1) (1) (41) (41) 2,560
Accounts payable
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 (0) 1 4,389 4,389 2,232
Refund liability - CMS advance payment
-
-
-
-
-
-
 - - 20,496 20,496 81,984
Accrued employee compensation
$45,679
$45,679
$45,679
$45,679
-
-
 - - - - -
Accrued compensation and employee benefits
-
-
-
-
$45,679
$45,679
 4 3 5,737 5,737 16,944
Accrued royalties
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 - - - - -
Accrued and other liabilities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 1 3 2,911 2,911 5,320
Deferred revenue
$45,679
$45,679
-
-
$45,679
$45,679
 (0) - - - -
Operating lease liabilities
-
-
-
-
-
-
 - (2) (1,475) (1,475) (1,516)
Net cash provided by (used in) operating activities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 ($4) ($3) $33,431 $33,431 $28,724
Selected Year:
31-Dec
2020
INVESTING ACTIVITIES
Cash spent on acquiring plant, equipment and other businesses, cash recei0 from sale of plant, equipment and subsidiaries as well cash parked temporarily in different securities - government bonds typically
SOURCEs
0%
100 %
0%
USES
7.1% 3.2% 89.7%
89.7% - Purchases of marketable securities
7.1% - Capital expenditures
3.2% - Purchases of intangible assets
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Purchases of marketable securities
-
-
-
-
-
-
 - - (90,034) (90,034) (360,136)
(Purchases) sale of investment securities
$45,679
-
-
-
-
-
 - - - - -
Maturities of investment securities
$45,679
-
-
-
-
-
 - - - - -
(Purchases) sale of equity securities
-
-
-
-
-
-
 - (1) - - -
Capital expenditures
-
-
-
-
-
$45,679
 (2) (2) (7,110) (7,110) (1,760)
(Purchase) sale of property and equipment
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 (2) - - - -
Purchases of intangible assets
-
-
-
-
$45,679
$45,679
 (5) (1) (3,250) (3,250) -
Acquisitions
$45,679
$45,679
$45,679
-
-
-
 - - - - -
Acquisition of Allenex AB net of cash
-
-
-
$45,679
$45,679
$45,679
 (1) - - - -
Acquisition of assets of Conexio Genomics Pty Ltd
-
-
-
$45,679
$45,679
$45,679
 - - - - -
Acquisition of business net of cash
-
-
-
-
-
$45,679
 (1) (18) - - -
Restricted cash on operating leases
-
-
-
$45,679
-
-
 - - - - -
Net cash provided by (used in) investing activities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 ($8) ($23) ($100,394) ($100,394) ($361,896)
Selected Year:
31-Dec
2020
FINANCING ACTIVITIES
Items in this group are concerned with borrowing funds, repaying debt, issuing equity, buying back shares, etc.
80.2% - Public equity offering
14.0% - Issuance of common stock via at-the-market (AMT) program
4.8% - Issuance of common stock from exercise of stock options
0.8% - Issuance of common stock under Employee Stock Purchase Plan (ESPP)
0.2% - Proceeds from exercise of warrants
SOURCEs
4.8% 80.2% 14.0%
100 %
0%
USES
97.2%
2.7% - Employee withholding taxes paid upon settlement of restricted stock units
0.1% - Finance leases and debt borrowing (repayment)
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Initial Public Offering (IPO) net
$45,679
-
$45,679
-
-
-
 - - - - -
Issuance of common stock
-
-
$45,679
$45,679
$45,679
$45,679
 53 - - - -
Public equity offering
-
-
-
-
-
-
 52,910 - 134,684 134,684 -
Issuance of common stock via at-the-market (AMT) program Issuance of common stock via at-the-market (AMT) program
-
-
-
-
-
-
 - - 23,451 23,451 -
Issuance of convertible preferred stock
$45,679
-
-
-
-
-
 - - - - -
Issuance of common stock under Employee Stock Purchase Plan (ESPP) Issuance of common stock under Employee Stock Purchase Plan (ESPP)
-
$45,679
$45,679
$45,679
$45,679
$45,679
 0 1 1,368 1,368 1,144
Issuance of common stock from exercise of stock options Issuance of common stock from exercise of stock options
-
-
-
-
-
-
 1,480 3,553 8,006 8,006 16,968
Proceeds from issuance of common stock upon exercise of stock options Proceeds from issuance of common stock upon exercise of stock options
$45,679
$45,679
-
$45,679
$45,679
$45,679
 1 4 - - -
Proceeds from exercise of warrants
-
-
-
$45,679
$45,679
$45,679
 11 0 352 352 36
Initial public offering costs
$45,679
-
$45,679
-
-
-
 - - - - -
Proceeds from private placement and subsequent financing net of issuance costs Proceeds from private placement and subsequent financing net of issuance costs
-
-
$45,679
-
$45,679
$45,679
 - - - - -
Borrowing (repayment) under Revolving Credit Facility
-
-
-
-
$45,679
$45,679
 (1) - - - -
Borrowing (repayment) under bank overdraft
-
-
-
$45,679
-
$45,679
 - - - - -
Borrowing (repayment) under subordinated convertible debt Borrowing (repayment) under subordinated convertible debt
$45,679
-
$45,679
-
-
-
 - - - - -
Repayment of debt
$45,679
-
-
-
-
-
 - - - - -
Borrowing
$45,679
$45,679
-
$45,679
$45,679
$45,679
 14 - - - -
Finance leases and debt borrowing (repayment)
-
-
-
-
-
-
 (28,089) (172) (183) (183) (188)
Repayment of debt and capital leases
-
$45,679
$45,679
$45,679
$45,679
$45,679
 (28) (0) - - -
Restricted cash collateral for debt
-
-
-
$45,679
-
-
 - - - - -
Acquisition-related contingent consideration payments
-
-
-
-
-
-
 (0) (0) - - -
Contingent payments related to Conexio Genomics Pty Ltd acquisition Contingent payments related to Conexio Genomics Pty Ltd acquisition
-
-
-
-
-
-
 (225) (225) - - -
Contingent payments related to the acquisition of Conexio Genomics Pty Ltd Contingent payments related to the acquisition of Conexio Genomics Pty Ltd
-
-
-
-
$45,679
$45,679
 (0) - - - -
Employee withholding taxes paid upon settlement of restricted stock units Employee withholding taxes paid upon settlement of restricted stock units
-
-
-
-
$45,679
$45,679
 (1) (4) (4,529) (4,529) (2,104)
Net cash provided by (used in) financing activities
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 $50 ($0) $163,149 $163,149 $15,856
Selected Year:
31-Dec
2020
NET CHANGE IN CASH
Grand Total for sum of cash flows coming from operations, investing and financing
$96,460,000
Selected Year:
Last Twelve Months LTM
Last Quarter Annualized LQA
Cash and equivalents - Beginning of period
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 $26 $65 $38,479 - $856,232
Effect of changes in foreign exchange rates on cash
-
-
$45,679
$45,679
$45,679
$45,679
 0 (1) 274 - 840
(Decrease) increase in cash and cash equivalents
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 38 (26) 96,460 - (316,476)
Cash and equivalents - End of period
$45,679
$45,679
$45,679
$45,679
$45,679
$45,679
 $65 $38 $134,939 - $539,756